WGU PHARMACOLOGY D441 OA
COMPREHENSIVE EXAMINATION STUDY
GUIDE Questions with Detailed Rationales Newest
Version 2026 | Verified Answers | Grade A+
Preparation
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
1. The four phases of the drug cycle in correct order are:
A. Distribution, Metabolism, Absorption, Excretion
B. Absorption, Distribution, Metabolism, Excretion
C. Metabolism, Absorption, Distribution, Excretion
D. Excretion, Absorption, Metabolism, Distribution
Answer: B
Rationale: The drug cycle follows the sequence of absorption (drug enters
bloodstream), distribution (drug transported to site of action), metabolism (drug
broken down by the liver), and excretion (drug eliminated from the body).
2. Which factor does NOT affect the rate of drug absorption?
A. pH of the medication
B. Concentration of medication
C. Length of contact with absorbing surface
D. Patient's blood type
Answer: D
Rationale: Absorption is affected by fat content, pH, medication concentration,
length of contact, age, food intake, and depth of breathing. Blood type does not
influence absorption rates.
3. A drug with a high therapeutic index indicates:
A. High risk of toxicity
B. A wide margin of safety between therapeutic and toxic doses
,C. The drug is only effective at toxic levels
D. The drug has no therapeutic effect
Answer: B
Rationale: A high therapeutic index means there is a large safety margin between
the effective dose and the toxic dose, making the drug relatively safe.
4. Bioavailability refers to:
A. The amount of drug that reaches systemic circulation
B. The speed at which a drug is excreted
C. The drug's ability to bind to proteins
D. The drug's half-life
Answer: A
Rationale: Bioavailability is the proportion of the administered drug that reaches
the systemic circulation in its active form.
5. First-pass effect occurs when:
A. A drug is metabolized in the liver before reaching systemic circulation
B. A drug is excreted unchanged in the urine
C. A drug binds to plasma proteins
D. A drug is administered intravenously
Answer: A
Rationale: The first-pass effect involves extensive hepatic metabolism of orally
administered drugs, reducing their bioavailability before they reach systemic
circulation.
6. Which route of administration bypasses the first-pass effect?
A. Oral
B. Sublingual
C. Rectal
D. Intravenous
,Answer: D
Rationale: Intravenous administration delivers the drug directly into systemic
circulation, completely bypassing first-pass hepatic metabolism.
7. Drug half-life is defined as:
A. The time required for the drug concentration to decrease by 50%
B. The total time a drug remains in the body
C. The time to reach peak drug concentration
D. The duration of therapeutic effect
Answer: A
Rationale: Half-life is the time needed for the plasma concentration of a drug to
fall to half its original value, determining dosing intervals.
8. Steady state is achieved when:
A. Drug administration equals drug elimination
B. The drug reaches its peak level
C. The drug is completely eliminated
D. The drug is first administered
Answer: A
Rationale: Steady state occurs when the rate of drug administration equals the rate
of elimination, resulting in consistent plasma drug levels.
9. Which organ is primarily responsible for drug metabolism?
A. Kidney
B. Liver
C. Heart
D. Lungs
Answer: B
Rationale: The liver is the primary site of drug metabolism, containing enzymes
(primarily cytochrome P450) that break down medications.
, 10. The therapeutic range of a drug refers to:
A. The concentration range producing therapeutic effects without toxicity
B. The maximum dose that can be administered
C. The minimum effective dose
D. The toxic concentration
Answer: A
Rationale: Therapeutic range is the plasma drug concentration between the
minimum effective concentration and the minimum toxic concentration.
11. Drug tolerance occurs when:
A. A patient experiences an allergic reaction
B. Increased drug doses are required to achieve the same effect
C. The drug is rapidly excreted
D. The drug binds to different receptors
Answer: B
Rationale: Tolerance develops when repeated drug administration results in
diminished effect, requiring higher doses to achieve the same therapeutic response.
12. Agonist drugs work by:
A. Binding to receptors and producing a response
B. Blocking receptors without producing a response
C. Inactivating enzymes
D. Increasing drug excretion
Answer: A
Rationale: Agonists bind to and activate receptors, producing a pharmacological
response similar to the endogenous substance.
13. Antagonist drugs function by:
A. Activating receptors to produce a response
B. Blocking receptor activation without producing a response
C. Increasing drug metabolism
D. Enhancing drug absorption
COMPREHENSIVE EXAMINATION STUDY
GUIDE Questions with Detailed Rationales Newest
Version 2026 | Verified Answers | Grade A+
Preparation
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
1. The four phases of the drug cycle in correct order are:
A. Distribution, Metabolism, Absorption, Excretion
B. Absorption, Distribution, Metabolism, Excretion
C. Metabolism, Absorption, Distribution, Excretion
D. Excretion, Absorption, Metabolism, Distribution
Answer: B
Rationale: The drug cycle follows the sequence of absorption (drug enters
bloodstream), distribution (drug transported to site of action), metabolism (drug
broken down by the liver), and excretion (drug eliminated from the body).
2. Which factor does NOT affect the rate of drug absorption?
A. pH of the medication
B. Concentration of medication
C. Length of contact with absorbing surface
D. Patient's blood type
Answer: D
Rationale: Absorption is affected by fat content, pH, medication concentration,
length of contact, age, food intake, and depth of breathing. Blood type does not
influence absorption rates.
3. A drug with a high therapeutic index indicates:
A. High risk of toxicity
B. A wide margin of safety between therapeutic and toxic doses
,C. The drug is only effective at toxic levels
D. The drug has no therapeutic effect
Answer: B
Rationale: A high therapeutic index means there is a large safety margin between
the effective dose and the toxic dose, making the drug relatively safe.
4. Bioavailability refers to:
A. The amount of drug that reaches systemic circulation
B. The speed at which a drug is excreted
C. The drug's ability to bind to proteins
D. The drug's half-life
Answer: A
Rationale: Bioavailability is the proportion of the administered drug that reaches
the systemic circulation in its active form.
5. First-pass effect occurs when:
A. A drug is metabolized in the liver before reaching systemic circulation
B. A drug is excreted unchanged in the urine
C. A drug binds to plasma proteins
D. A drug is administered intravenously
Answer: A
Rationale: The first-pass effect involves extensive hepatic metabolism of orally
administered drugs, reducing their bioavailability before they reach systemic
circulation.
6. Which route of administration bypasses the first-pass effect?
A. Oral
B. Sublingual
C. Rectal
D. Intravenous
,Answer: D
Rationale: Intravenous administration delivers the drug directly into systemic
circulation, completely bypassing first-pass hepatic metabolism.
7. Drug half-life is defined as:
A. The time required for the drug concentration to decrease by 50%
B. The total time a drug remains in the body
C. The time to reach peak drug concentration
D. The duration of therapeutic effect
Answer: A
Rationale: Half-life is the time needed for the plasma concentration of a drug to
fall to half its original value, determining dosing intervals.
8. Steady state is achieved when:
A. Drug administration equals drug elimination
B. The drug reaches its peak level
C. The drug is completely eliminated
D. The drug is first administered
Answer: A
Rationale: Steady state occurs when the rate of drug administration equals the rate
of elimination, resulting in consistent plasma drug levels.
9. Which organ is primarily responsible for drug metabolism?
A. Kidney
B. Liver
C. Heart
D. Lungs
Answer: B
Rationale: The liver is the primary site of drug metabolism, containing enzymes
(primarily cytochrome P450) that break down medications.
, 10. The therapeutic range of a drug refers to:
A. The concentration range producing therapeutic effects without toxicity
B. The maximum dose that can be administered
C. The minimum effective dose
D. The toxic concentration
Answer: A
Rationale: Therapeutic range is the plasma drug concentration between the
minimum effective concentration and the minimum toxic concentration.
11. Drug tolerance occurs when:
A. A patient experiences an allergic reaction
B. Increased drug doses are required to achieve the same effect
C. The drug is rapidly excreted
D. The drug binds to different receptors
Answer: B
Rationale: Tolerance develops when repeated drug administration results in
diminished effect, requiring higher doses to achieve the same therapeutic response.
12. Agonist drugs work by:
A. Binding to receptors and producing a response
B. Blocking receptors without producing a response
C. Inactivating enzymes
D. Increasing drug excretion
Answer: A
Rationale: Agonists bind to and activate receptors, producing a pharmacological
response similar to the endogenous substance.
13. Antagonist drugs function by:
A. Activating receptors to produce a response
B. Blocking receptor activation without producing a response
C. Increasing drug metabolism
D. Enhancing drug absorption
